Vox Royalty is expected to excel in cost control, leveraging the scalability feature of the royalty business model. See why I ...

Understanding this evolutionary process is doubly interesting to me because it's pervasive: it can be found in a number of ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our recommendation for VRTX stock.

Cathie Wood has recently predicted that Tesla will reach $2600/share in five years' time. See why I reiterate my strong sell ...

Despite a weak Q4'24, Pollard Banknote's (PBL:CA) charitable gaming segment and NeoPollard JV show strong potential. See why ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

Novanta's growth has been a bit sluggish in recent years. Click here to read why I will be keen to pick up and initiate a ...

With a growing base of over 300 million subscribers, Netflix cemented itself as a Need rather than a Want. Read why I ...

Horizon Technology Finance offers two baby bonds, HTFB and HTFC. Click here to read why HTFC currently presents a strong buy ...

United Rentals' counter-cyclical cash flow model and low leverage position it well to navigate economic uncertainties. Read ...

Monroe Capital's leverage increased to 1.53 times debt to equity, further exacerbating financial instability. Read why MRCC ...

Shipping shares joined the broader stock market carnage after China responded to President Trump's tariffs with its own ...